Online-Ressource | |
Verfasst von: | Keubler, Anja [VerfasserIn] |
Weiß, Johanna [VerfasserIn] | |
Haefeli, Walter E. [VerfasserIn] | |
Mikus, Gerd [VerfasserIn] | |
Burhenne, Jürgen [VerfasserIn] | |
Titel: | Drug interaction of efavirenz and midazolam |
Titelzusatz: | efavirenz activates the CYP3A-mediated midazolam 1′-Hydroxylation in vitro |
Verf.angabe: | Anja Keubler, Johanna Weiss, Walter E. Haefeli, Gerd Mikus, Jürgen Burhenne |
E-Jahr: | 2012 |
Jahr: | May 16, 2012 |
Umfang: | 5 S. |
Fussnoten: | Published online May 16, 2012 ; Gesehen am 14.08.2018 |
Titel Quelle: | Enthalten in: Drug metabolism and disposition |
Ort Quelle: | Bethesda, Md. : ASPET, 1973 |
Jahr Quelle: | 2012 |
Band/Heft Quelle: | 40(2012), 6, Seite 1178-1182 |
ISSN Quelle: | 1521-009X |
Abstract: | CYP3A4 and CYP3A5 are the most important drug-metabolizing enzymes. For several drugs, heteroactivation of CYP3A-mediated reactions has been demonstrated in vitro. In vivo data suggested a possible acute activation of CYP3A4-catalyzed midazolam metabolism by efavirenz. Therefore, we aimed to investigate the effect of efavirenz on the in vitro metabolism of midazolam. The formation of 1′-hydroxymidazolam was studied in pooled human liver microsomes (HLM) and recombinant human CYP3A4 and CYP3A5 (rCYP3A4 and rCYP3A5) in the presence of efavirenz (0.5, 1, and 5 μM). Product formation rates (Vmax) increased with increasing efavirenz concentrations (∼1.5-fold increase at 5 μM efavirenz in HLM and ∼1.4-fold in rCYP3A4). The activation in rCYP3A4 was dependent on cytochrome b5, and the activating effect was also observed in rCYP3A5 supplemented with cytochrome b5, where Vmax was ∼1.3-fold enhanced. Concomitant inhibition of CYP3A activity with ketoconazole in HLM abolished the increase in the 1′-hydroxymidazolam formation rate, further confirming involvement of CYP3A. The results of this study represent a distinct acute activation of midazolam metabolism and support the in vivo observations. Moreover, only efavirenz, but not its major metabolite 8-hydroxyefavirenz, was responsible for the activation. The increase in 1′-hydroxymidazolam formation may have been caused by binding of efavirenz to a peripheral site of the enzyme, leading to enhanced midazolam turnover due to changes at the active site. |
DOI: | doi:10.1124/dmd.111.043844 |
URL: | Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt. Volltext ; Verlag: http://dx.doi.org/10.1124/dmd.111.043844 |
Volltext: http://dmd.aspetjournals.org/content/40/6/1178 | |
DOI: https://doi.org/10.1124/dmd.111.043844 | |
Datenträger: | Online-Ressource |
Sprache: | eng |
K10plus-PPN: | 1579234925 |
Verknüpfungen: | → Zeitschrift |